Polymicrobial etiology as a prognostic factor for empyema in addition to the renal, age, purulence, infection source, and dietary factors score [0.03%]
联合肾脏因素、年龄、脓性分泌物、感染源和饮食因素评分评估多微生物病原体引起的脓胸预后价值较高
Akio Yamazaki,Akihiro Ito,Tadashi Ishida et al.
Akio Yamazaki et al.
Background: Empyema is an important and serious disease with high morbidity and mortality worldwide. However, the bacteriology and prognostic factors of empyema remain poorly understood, and data on the relationships amon...
Variation in interferon-γ production between QFT-Plus and QFT-GIT assays in TB contact investigation [0.03%]
QFT-Plus和QFT-GIT试验在结核接触者筛查中的差异分析
Mizue Tsuyuzaki,Hidetoshi Igari,Nao Okada et al.
Mizue Tsuyuzaki et al.
Background: Individuals with recent contact with active tuberculosis (TB) patients were screened for latent tuberculosis infection (LTBI) considering their greater relative risk for developing active TB. QuantiFERON®-TB ...
Masaomi Marukawa,Akihiko Taniguchi,Goro Kimura et al.
Masaomi Marukawa et al.
Background: The prevalence of Mycobacterium avium complex (MAC) pulmonary disease (PD) is increasing significantly in Japan. Among the patterns of MAC-PD, a solitary pulmonary nodule (SPN) is less common and often resembl...
Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia [0.03%]
日本呼吸器学会肺癌合并间质性肺炎诊疗声明概要
Takashi Ogura,Nagio Takigawa,Keisuke Tomii et al.
Takashi Ogura et al.
Dramatic progress in targeted therapy and immunotherapy has been changing clinical practices in lung cancer. With the accumulation of clinical practice, it has become clear that pre-existing interstitial pneumonia (IP) could be a risk facto...
Probe-based optical fiberscopy for the direct observation of peripheral pulmonary lesions [0.03%]
用于直接观察周围型肺部病变的光纤内窥成像技术
Makoto Kosaka,Masanori Yasuo,Fumiya Kinota et al.
Makoto Kosaka et al.
Background: Peripheral pulmonary lesions are rarely observed directly before transbronchial biopsy. This study aimed to characterize the differences between malignant and benign peripheral pulmonary lesions according to t...
Association of specific metastatic organs with the prognosis and chemotherapeutic response in patients with advanced lung cancer [0.03%]
特定转移器官与晚期肺癌患者预后及化疗反应的关系分析
Nobuhiro Kanaji,Akira Tadokoro,Naoki Watanabe et al.
Nobuhiro Kanaji et al.
Background: This study was performed to investigate the influence of specific metastatic organs on the prognosis and therapeutic effect in patients with advanced lung cancer. ...
Objective measurement of nocturnal cough in infants with acute bronchiolitis [0.03%]
急性细支气管炎婴儿夜间咳嗽的客观检测方法研究
Kota Hirai,Mariko Nukaga,Hideyuki Tabata et al.
Kota Hirai et al.
Objectives: The objective measurement of the cough severity and the assessment of the pattern of nocturnal coughing could be useful in the treatment of respiratory diseases in children. ...
Outcomes of prolonged mechanical ventilation in patients who underwent bedside percutaneous dilatation tracheostomy in intermediate care units - A single center study [0.03%]
长时间机械通气行床旁经皮扩张气管切开术患者的预后研究-单中心研究
Oded Cohen,Ruth Shnipper,Dekel Stavi et al.
Oded Cohen et al.
Background: The number of chronic critical illness (CCI) patients requiring prolonged mechanical ventilation (PMV) is increasing worldwide, mandating health professionals to discuss interventions while considering disease...
Interstitial pneumonitis associated with dasatinib: two case reports and literature review [0.03%]
达沙替尼相关间质性肺炎2例报告及文献复习
Yuhei Ito,Motoaki Tanigawa,Keisuke Iwamoto et al.
Yuhei Ito et al.
Dasatinib has increasingly been used to treat chronic myeloid leukemia (CML), although interstitial pneumonitis has been found as a complication in large clinical trials. In the present study, 23 patients received dasatinib for CML between ...
Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer [0.03%]
既往间质性肺病异常是非小细胞肺癌免疫检查点抑制剂相关性肺炎的危险因素
Yu Nakanishi,Takeshi Masuda,Kakuhiro Yamaguchi et al.
Yu Nakanishi et al.
Background: Approximately 5% of non-small cell lung cancer (NSCLC) patients develop immune checkpoint inhibitor (ICI)-induced interstitial lung disease (ICI-ILD), 10% of whom die. However, there are no established risk fa...